SCHEMBL1950901

SCHEMBL1950901

CCC(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CTNNB1 P35222 10/20 0.57
▸ WNT3A P56704 10/20 0.57
▸ LMNA P02545 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ PDK2 Q15119 1/20 0.48
▸ F2R P25116 1/20 0.47
▸ KCNK3 O14649 1/20 0.45
▸ KCNK9 Q9NPC2 1/20 0.45
▸ CNR2 P34972 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29410857 1.00 CTNNB1 (0.57) CTNNB1WNT3ALMNAGAAPDK2
Hydrochloric Acid SCHEMBL5819908 0.98 CTNNB1 (0.55) CTNNB1WNT3ALMNAGAAPDK2
SCHEMBL8439499 0.86 LMNA (0.53) CTNNB1WNT3ALMNAGAAF2R
SCHEMBL18662346 0.85 CTNNB1 (0.62) CTNNB1WNT3ALMNAGAAF2R
SCHEMBL30089582 0.84 CTNNB1 (0.75) CTNNB1WNT3ALMNAGAAF2R
SCHEMBL24450817 0.84 PDK2 (0.44) CTNNB1WNT3ALMNAGAAPDK2
SCHEMBL28798676 0.84 CTSS (0.55) CTNNB1WNT3ALMNAGAAPDK2
SCHEMBL4873112 0.84 CTSS (0.55) CTNNB1WNT3ALMNAGAAPDK2
SCHEMBL11297486 0.82 ALDH1A1 (0.43) CTNNB1WNT3AGAAPDK2
SCHEMBL19858887 0.82 CTNNB1 (0.58) CTNNB1WNT3ALMNAGAAKCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3196183-B1 METHOD FOR PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE TORAY FINECHEMICALS CO LTD (JP) 2019-05-01 — — EP claimed
CN-106029620-B The manufacture method of 2 ' trifluoromethyl substituted aroma race ketone 东丽精细化工株式会社 2018-01-30 — — CN claimed
US-9783476-B2 Method of producing 2′-trifluoromethyl group-substituted aromatic ketone TORAY FINE CHEMICALS CO., LTD. (JP) 2017-10-10 — — US claimed
EP-3196183-A1 METHOD FOR PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE Toray Fine Chemicals Co., Ltd. (JP) 2017-07-26 — — EP claimed
US-20170088499-A1 METHOD OF PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE TORAY FINE CHEMICALS CO., LTD. (JP) 2017-03-30 — — US claimed
CN-106029620-A Method for producing 2'-trifluoromethyl group-substituted aromatic ketone 东丽精细化工株式会社 2016-10-12 — — CN claimed
US-9201318-B2 Polymer for charge generation layer and charge transport layer formulation XEROX CORPORATION (US) 2015-12-01 — — US claimed
CN-104311397-A Novel fluorine-containing bisphenol compound and preparation method thereof WUHAN INST OF SHIPBUILDING TECHNOLOGY CO LTD 2015-01-28 — — CN claimed
US-20150024310-A1 POLYMER FOR CHARGE GENERATION LAYER AND CHARGE TRANSPORT LAYER FORMULATION XEROX CORPORATION 2015-01-22 — — US claimed
US-8877413-B2 Flexible imaging members comprising improved ground strip XEROX CORPORATION (US) 2014-11-04 — — US claimed
US-8614038-B2 Plasticized anti-curl back coating for flexible imaging member XEROX CORPORATION (US) 2013-12-24 — — US claimed
US-20130216266-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2013-08-22 — — US claimed
US-20130202995-A1 PLASTICIZED ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBER XEROX CORPORATION (US) 2013-08-08 — — US claimed
US-20130052576-A1 FLEXIBLE IMAGING MEMBERS COMPRISING IMPROVED GROUND STRIP XEROX CORPORATION (US) 2013-02-28 — — US claimed
US-8343700-B2 Imaging members having stress/strain free layers XEROX CORPORATION (US) 2013-01-01 — — US claimed
US-8232030-B2 Curl-free imaging members with a slippery surface XEROX CORPORATION (US) 2012-07-31 — — US claimed
US-20110256474-A1 IMAGING MEMBERS HAVING STRESS/STRAIN FREE LAYERS XEROX CORPORATION (US) 2011-10-20 — — US claimed
US-20110229808-A1 CURL-FREE IMAGING MEMBERS WITH A SLIPPERY SURFACE XEROX CORPORATION (US) 2011-09-22 — — US claimed
US-20110136049-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2011-06-09 — — US claimed
CN-114456098-B Preparation method of medicine Ai Shali ketone for treating diabetic nephropathy 大连理工大学 2024-06-14 — — CN disclosed
CN-114702427-A Pyrrole amide compound and application thereof 年衍药业(珠海)有限公司 2022-07-05 — — CN disclosed
CN-114456098-A Preparation method of diabetic nephropathy medicine namely elsamiloride 大连理工大学 2022-05-10 — — CN disclosed
CN-112707854-B Pyrrole amide compound and application thereof 年衍药业(珠海)有限公司 2022-03-15 — — CN disclosed
CN-112830879-A Preparation method of cinacalcet hydrochloride 北京泰德制药股份有限公司 2021-05-25 — — CN disclosed
WO-2021078135-A1 PYRROLE AMIDE COMPOUND AND USE THEREOF 广东东阳光药业有限公司 2021-04-29 — — WO disclosed
CN-112707854-A Pyrrole amide compound and application thereof 广东东阳光药业有限公司 2021-04-27 — — CN disclosed
CN-106496127-B A kind of preparation method of polysubstituted pyrimidine 苏州大学 2019-09-27 — — CN disclosed
US-10308604-B2 Method for producing pyrrole derivative, and intermediate thereof DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-06-04 — — US disclosed
EP-3196183-B1 METHOD FOR PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE TORAY FINECHEMICALS CO LTD (JP) 2019-05-01 — — EP disclosed
EP-3190102-B1 CRYSTAL OF (S)-1-(2-HYDROXYETHYL)-4-METHYL-N- [4-(METHYLSULFONYL)PHENYL]-5-[2-(TRIFLUOROMETHYL)& xA;PHENYL]- 1H-PYRROLE-3-CARBOXAMIDE DAIICHI SANKYO CO LTD (JP) 2018-09-12 — — EP disclosed
EP-1773768-B1 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2018-08-22 — — EP disclosed
EP-3113618-B1 HETEROCYCLIC COMPOUNDS AS PEST CONTROLLERS BAYER CROPSCIENCE AG (DE) 2018-07-04 — — EP disclosed
CN-104955454-B Chemokine receptor anagonists 凯莫森特里克斯股份有限公司 2018-06-29 — — CN disclosed
US-10005725-B2 Method for producing pyrrole derivative, and intermediate thereof DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-06-26 — — US disclosed
US-20180044284-A1 NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-02-15 — — US disclosed
US-20180044284-A1 NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-02-15 — — US disclosed
CN-106029620-B The manufacture method of 2 ' trifluoromethyl substituted aroma race ketone 东丽精细化工株式会社 2018-01-30 — — CN disclosed
EP-2985277-B1 METHOD FOR PREPARING AN ATROPISOMER OF A PYRROLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2018-01-17 — — EP disclosed
EP-3040330-B1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF DAIICHI SANKYO CO LTD (JP) 2018-01-10 — — EP disclosed
US-20170369438-A1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-12-28 — — US disclosed
CN-107266413-A Heterocycle and phenylpropionic acid derivative and its preparation method and application 上海大学 2017-10-20 — — CN disclosed
CN-107254454-A A kind of carbonyl reduction enzyme mutant and its application 中国科学院成都生物研究所 2017-10-17 — — CN disclosed
US-9783476-B2 Method of producing 2′-trifluoromethyl group-substituted aromatic ketone TORAY FINE CHEMICALS CO., LTD. (JP) 2017-10-10 — — US disclosed
US-9776961-B2 Crystal of pyrrole derivative and method for producing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-10-03 — — US disclosed
US-9765025-B2 Method for producing pyrrole derivative, and intermediate thereof DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-09-19 — — US disclosed
CN-107141209-A A kind of α position cycloalkyls replace the synthetic method of ketone compounds 河南师范大学 2017-09-08 — — CN disclosed
EP-1844020-B1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS INC (US) 2017-09-06 — — EP disclosed
US-20170233341-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-08-17 — — US disclosed
EP-3196183-A1 METHOD FOR PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE Toray Fine Chemicals Co., Ltd. (JP) 2017-07-26 — — EP disclosed
EP-3190102-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME Daiichi Sankyo Company, Limited (JP) 2017-07-12 — — EP disclosed
US-9676713-B2 Crystal of pyrrole derivative and method for producing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-06-13 — — US disclosed
US-20170088499-A1 METHOD OF PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE TORAY FINE CHEMICALS CO., LTD. (JP) 2017-03-30 — — US disclosed
US-20170057915-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-03-02 — — US disclosed
US-9499483-B2 Crystal of pyrrole derivative and method for producing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-11-22 — — US disclosed
CN-106029620-A Method for producing 2'-trifluoromethyl group-substituted aromatic ketone 东丽精细化工株式会社 2016-10-12 — — CN disclosed
US-20160237034-A1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-08-18 — — US disclosed
EP-3040330-A1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-07-06 — — EP disclosed
US-20160096803-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-04-07 — — US disclosed
EP-2985277-A1 DIPYRROMETHENE CRYSTAL AND METHOD FOR MANUFACTURING SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-02-17 — — EP disclosed
US-9201318-B2 Polymer for charge generation layer and charge transport layer formulation XEROX CORPORATION (US) 2015-12-01 — — US disclosed
US-9201318-B2 Polymer for charge generation layer and charge transport layer formulation XEROX CORPORATION (US) 2015-12-01 — — US disclosed
US-9201318-B2 Polymer for charge generation layer and charge transport layer formulation XEROX CORPORATION (US) 2015-12-01 — — US disclosed
CN-104311397-A Novel fluorine-containing bisphenol compound and preparation method thereof WUHAN INST OF SHIPBUILDING TECHNOLOGY CO LTD 2015-01-28 — — CN disclosed
US-20150024310-A1 POLYMER FOR CHARGE GENERATION LAYER AND CHARGE TRANSPORT LAYER FORMULATION XEROX CORPORATION 2015-01-22 — — US disclosed
US-20150024310-A1 POLYMER FOR CHARGE GENERATION LAYER AND CHARGE TRANSPORT LAYER FORMULATION XEROX CORPORATION 2015-01-22 — — US disclosed
US-20150024310-A1 POLYMER FOR CHARGE GENERATION LAYER AND CHARGE TRANSPORT LAYER FORMULATION XEROX CORPORATION 2015-01-22 — — US disclosed
CN-102056907-B Heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL 2014-12-31 — — CN disclosed
US-8877413-B2 Flexible imaging members comprising improved ground strip XEROX CORPORATION (US) 2014-11-04 — — US disclosed
US-8877413-B2 Flexible imaging members comprising improved ground strip XEROX CORPORATION (US) 2014-11-04 — — US disclosed
US-8877413-B2 Flexible imaging members comprising improved ground strip XEROX CORPORATION (US) 2014-11-04 — — US disclosed
US-8835085-B2 Low strain anti-curl back coating for flexible imaging members XEROX CORPORATION (US) 2014-09-16 — — US disclosed
US-8835085-B2 Low strain anti-curl back coating for flexible imaging members XEROX CORPORATION (US) 2014-09-16 — — US disclosed
US-8835085-B2 Low strain anti-curl back coating for flexible imaging members XEROX CORPORATION (US) 2014-09-16 — — US disclosed
CN-103998451-A Substituted bicyclic azaheterocyclic compounds and analogs as sirtuin modulators GLAXOSMITHKLINE LLC 2014-08-20 — — CN disclosed
US-20140087297-A1 LOW STRAIN ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBERS XEROX CORPORATION (US) 2014-03-27 — — US disclosed
US-20140087297-A1 LOW STRAIN ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBERS XEROX CORPORATION (US) 2014-03-27 — — US disclosed
US-20140087297-A1 LOW STRAIN ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBERS XEROX CORPORATION (US) 2014-03-27 — — US disclosed
CN-103562200-A Novel imidazole derivatives useful for the treatment of arthritis LILLY CO ELI 2014-02-05 — — CN disclosed
US-8614038-B2 Plasticized anti-curl back coating for flexible imaging member XEROX CORPORATION (US) 2013-12-24 — — US disclosed
CN-102307852-B Cyclic amine compounds DAIICHI SANKYO CO LTD 2013-12-18 — — CN disclosed
CN-101006052-B Pyrrole derivatives as pharmaceutical agents EXELIXIS INC 2013-11-06 — — CN disclosed
US-20130216266-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2013-08-22 — — US disclosed
US-20130216266-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2013-08-22 — — US disclosed
US-20130216266-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2013-08-22 — — US disclosed
US-20130202995-A1 PLASTICIZED ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBER XEROX CORPORATION (US) 2013-08-08 — — US disclosed
US-20130202995-A1 PLASTICIZED ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBER XEROX CORPORATION (US) 2013-08-08 — — US disclosed
US-20130202995-A1 PLASTICIZED ANTI-CURL BACK COATING FOR FLEXIBLE IMAGING MEMBER XEROX CORPORATION (US) 2013-08-08 — — US disclosed
US-20130052576-A1 FLEXIBLE IMAGING MEMBERS COMPRISING IMPROVED GROUND STRIP XEROX CORPORATION (US) 2013-02-28 — — US disclosed
US-20130052576-A1 FLEXIBLE IMAGING MEMBERS COMPRISING IMPROVED GROUND STRIP XEROX CORPORATION (US) 2013-02-28 — — US disclosed
US-20130052576-A1 FLEXIBLE IMAGING MEMBERS COMPRISING IMPROVED GROUND STRIP XEROX CORPORATION (US) 2013-02-28 — — US disclosed
US-8367667-B2 Pyrrole derivatives as pharmaceutical agents EXELIXIS, INC. (US) 2013-02-05 — — US disclosed
US-8343700-B2 Imaging members having stress/strain free layers XEROX CORPORATION (US) 2013-01-01 — — US disclosed
US-8343700-B2 Imaging members having stress/strain free layers XEROX CORPORATION (US) 2013-01-01 — — US disclosed
US-8343700-B2 Imaging members having stress/strain free layers XEROX CORPORATION (US) 2013-01-01 — — US disclosed
WO-2012161965-A1 NOVEL IMIDAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF ARTHRITIS ELI LILLY AND COMPANY (US) 2012-11-29 — — WO disclosed
US-8263298-B1 Electrically tunable and stable imaging members XEROX CORPORATION (US) 2012-09-11 — — US disclosed
US-8263298-B1 Electrically tunable and stable imaging members XEROX CORPORATION (US) 2012-09-11 — — US disclosed
US-8263298-B1 Electrically tunable and stable imaging members XEROX CORPORATION (US) 2012-09-11 — — US disclosed
US-20120219893-A1 ELECTRICALLY TUNABLE AND STABLE IMAGING MEMBERS XEROX CORPORATION (US) 2012-08-30 — — US disclosed
US-20120219893-A1 ELECTRICALLY TUNABLE AND STABLE IMAGING MEMBERS XEROX CORPORATION (US) 2012-08-30 — — US disclosed
US-20120219893-A1 ELECTRICALLY TUNABLE AND STABLE IMAGING MEMBERS XEROX CORPORATION (US) 2012-08-30 — — US disclosed
US-8232030-B2 Curl-free imaging members with a slippery surface XEROX CORPORATION (US) 2012-07-31 — — US disclosed
US-8232030-B2 Curl-free imaging members with a slippery surface XEROX CORPORATION (US) 2012-07-31 — — US disclosed
US-8232030-B2 Curl-free imaging members with a slippery surface XEROX CORPORATION (US) 2012-07-31 — — US disclosed
US-20110301128-A1 Pyrrole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2011-12-08 — — US disclosed
US-20110256474-A1 IMAGING MEMBERS HAVING STRESS/STRAIN FREE LAYERS XEROX CORPORATION (US) 2011-10-20 — — US disclosed
US-20110256474-A1 IMAGING MEMBERS HAVING STRESS/STRAIN FREE LAYERS XEROX CORPORATION (US) 2011-10-20 — — US disclosed
US-20110256474-A1 IMAGING MEMBERS HAVING STRESS/STRAIN FREE LAYERS XEROX CORPORATION (US) 2011-10-20 — — US disclosed
US-8026237-B2 For modulating activity of one or more steroid nuclear receptors and for treatment, prevention, or amelioration of symptoms of disease or disorder related to the activity of receptors; 5-benzo[b]thiophen-2-yl-1,4-dimethyl-1H-pyrrole-3-carboxylic acid (4-methanesulfonyl-phenyl)-amide EXELIXIS, INC. (US) 2011-09-27 — — US disclosed
US-20110229808-A1 CURL-FREE IMAGING MEMBERS WITH A SLIPPERY SURFACE XEROX CORPORATION (US) 2011-09-22 — — US disclosed
US-20110229808-A1 CURL-FREE IMAGING MEMBERS WITH A SLIPPERY SURFACE XEROX CORPORATION (US) 2011-09-22 — — US disclosed
US-20110229808-A1 CURL-FREE IMAGING MEMBERS WITH A SLIPPERY SURFACE XEROX CORPORATION (US) 2011-09-22 — — US disclosed
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 — — US disclosed
US-20110144128-A1 Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands EXELIXIS, INC. (US) 2011-06-16 — — US disclosed
US-20110136049-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2011-06-09 — — US disclosed
US-20110136049-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2011-06-09 — — US disclosed
US-20110136049-A1 IMAGING MEMBERS COMPRISING FLUOROKETONE XEROX CORPORATION (US) 2011-06-09 — — US disclosed
US-20100280021-A1 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS BERTHEL STEVEN JOSEPH 2010-11-04 — — US disclosed
CN-101765430-A Novel pyrazole derivatives HOFFMANN LA ROCHE 2010-06-30 — — CN disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 — — EP disclosed
JP-2009298715-A METHOD FOR PRODUCING HIGH PURITY 2'-TRIFLUOROMETHYLPROPIOPHENONE CENTRAL GLASS CO LTD 2009-12-24 — — JP disclosed
EP-1910359-B1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS HOFFMANN LA ROCHE (CH) 2009-11-18 — — EP disclosed
US-20090192138-A1 COMPOUNDS BAESCHLIN DANIEL KASPAR 2009-07-30 — — US disclosed
WO-2008068625-A9 PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE AND POLYMORPHIC FORMS THEREOF MEDICHEM SA (ES) 2009-03-26 — — WO disclosed
US-20090062276-A1 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS BERTHEL STEVEN JOSEPH 2009-03-05 — — US disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 — — US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 — — WO disclosed
US-20080234270-A1 Pyrrole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2008-09-25 — — US disclosed
CN-101243081-A Pyrido[2,3-d]pyrimidine-2,4-diamine compounds as PTP1B inhibitors HOFFMANN LA ROCHE (CH) 2008-08-13 — — CN disclosed
EP-1773768-A4 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2008-08-06 — — EP disclosed
EP-1910359-A1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS F. Hoffmann-Roche AG (CH) 2008-04-16 — — EP disclosed
EP-1844020-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS Exelixis, Inc. (US) 2007-10-17 — — EP disclosed
CN-101006052-A Pyrrole derivatives as pharmaceutical agents EXELIXIS INC (US) 2007-07-25 — — CN disclosed
EP-1773768-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2007-04-18 — — EP disclosed
WO-2007024744-A2 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS, INC. (US) 2007-03-01 — — WO disclosed
WO-2007024744-A2 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS, INC. (US) 2007-03-01 — — WO disclosed
WO-2007009911-A1 PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-25 — — WO disclosed
US-20070021445-A1 Pyridopyrimidine protein tyrosine phosphatase inhibitors BERTHEL STEVEN J 2007-01-25 — — US disclosed
WO-2006112565-A1 THERAPEUTIC DRUGS FOR POLLAKIURIA AND URINARY INCONTINENCE CONTAINING OPTICAL ACTIVE PROPIOPHENON AND ITS SALTS DREAMPHARMA CORP. (KR) 2006-10-26 — — WO disclosed
WO-2006076202-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTORS LIGANDS EXELIXIS, INC. (US) 2006-07-20 — — WO disclosed
US-20060161004-A1 Novel compounds GLAXOSMITHKLINE SPA 2006-07-20 — — US disclosed
WO-2006012642-A2 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2006-02-02 — — WO disclosed
US-20050070574-A1 Novel compounds GLAXOSMITHKLINE SPA AND LABORATOIRE 2005-03-31 — — US disclosed
US-20040102633-A1 Novel compounds GLAXOSMITHKLINE S.P.A. (IT) 2004-05-27 — — US disclosed
CN-1151138-C Triazole antifungal agent ������������ʽ���� 2004-05-26 — — CN disclosed
EP-1339691-A1 NOVEL COMPOUNDS GlaxoSmithKline S.p.A. (IT) 2003-09-03 — — EP disclosed
CN-1090617-C Pyrrole derivatives and pharmaceutical compositions NIPPON SHINYAKU CO LTD (JP) 2002-09-11 — — CN disclosed
WO-2002044154-A1 NOVEL COMPOUNDS GLAXOSMITHKLINE SPA (IT) 2002-06-06 — — WO disclosed
CN-1349796-A Pyrrole derivatives and medicine composition NIPPON SHINYAKU CO LTD (JP) 2002-05-22 — — CN disclosed
CN-1049884-C Synthesis process of methylbenzyl acetone trihalide PUDONG PHARMACEUTICAL FACTORY (CN) 2000-03-01 — — CN disclosed
CN-1186485-A Pyrrole derivatives and pharmaceutical compositions NIPPON SHINYAKU CO LTD (JP) 1998-07-01 — — CN disclosed
CN-1174187-A Synthesis process of methylbenzyl acetone trihalide PUDONG PHARMACEUTICAL FACTORY (CN) 1998-02-25 — — CN disclosed
EP-0200942-B1 NEW DERIVATIVES OF AN AMINOKETONE NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1993-08-25 — — EP disclosed
US-5103022-A Reacting dl-2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidino -1-propanone with l-acetylphenylglycine to form corresponding diastereomeric salt, deposition, isolation of l-2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidino-1-propanone NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1992-04-07 — — US disclosed
US-5057535-A Muscle relaxants NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1991-10-15 — — US disclosed
EP-0200942-A2 New derivatives of an aminoketone NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1986-11-12 — — EP disclosed
US-4596816-A Pharmaceuticals TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-06-24 — — US disclosed
EP-0092239-A2 Oxazole derivatives, production and use thereof Takeda Chemical Industries, Ltd. (JP) 1983-10-26 — — EP disclosed
EP-0092239-A2 Oxazole derivatives, production and use thereof Takeda Chemical Industries, Ltd. (JP) 1983-10-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (20 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301128-A1 Pyrrole Derivatives As Pharmaceutical Agents PRLHR, PTGDR, TACR1 CTNNB1 4800/4885WNT3A 3884/4885LMNA 4213/4885
US-20050070574-A1 Novel compounds NR1H3, NR1H2, CNR1 CTNNB1 2631/4885WNT3A 3111/4885LMNA 3533/4885
US-10308604-B2 Method for producing pyrrole derivative, and intermediate thereof NR3C2, MC2R, CYP11B2 CTNNB1 4201/4885WNT3A 2931/4885LMNA 4062/4885
US-20170369438-A1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF NR3C2, MC2R, CYP11B2 CTNNB1 4201/4885WNT3A 2931/4885LMNA 4062/4885
US-20080234270-A1 Pyrrole Derivatives As Pharmaceutical Agents PRLHR, PTGDR, TACR1 CTNNB1 4800/4885WNT3A 3884/4885LMNA 4213/4885
US-20090062276-A1 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS PTPRF, PTPN1, PTPRCAP CTNNB1 2561/4885WNT3A 2847/4885LMNA 4736/4885
US-20060161004-A1 Novel compounds SLC10A1, ABCB11, AQP1 CTNNB1 3098/4885WNT3A 1891/4885LMNA 2220/4885
US-20160237034-A1 METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF NR3C2, MC2R, CYP11B2 CTNNB1 4201/4885WNT3A 2931/4885LMNA 4062/4885
US-20090192138-A1 COMPOUNDS DPP4, DPP3, DPP8 CTNNB1 4063/4885WNT3A 1587/4885LMNA 3764/4885
US-20180044284-A1 NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS PLG, PPARG, PKLR CTNNB1 3143/4885WNT3A 4199/4885LMNA 910/4885
US-20170088499-A1 METHOD OF PRODUCING 2'-TRIFLUOROMETHYL GROUP-SUBSTITUTED AROMATIC KETONE GRIK4, GRIK2, CYP4F12 CTNNB1 4213/4885WNT3A 3263/4885LMNA 3695/4885
US-20170057915-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME NR3C2, MC2R, CRHR1 CTNNB1 2715/4885WNT3A 1560/4885LMNA 2076/4885
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 CTNNB1 3391/4885WNT3A 2695/4885LMNA 4701/4885
US-20160096803-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME NR3C2, MC2R, CRHR1 CTNNB1 2715/4885WNT3A 1560/4885LMNA 2076/4885
US-20110144128-A1 Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands NCOA1, NCOA2, NCOA3 CTNNB1 2747/4885WNT3A 3738/4885LMNA 2007/4885
US-20040102633-A1 Novel compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, NR1H3 CTNNB1 2197/4885WNT3A 3573/4885LMNA 2824/4885
US-20170233341-A1 CRYSTAL OF PYRROLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME NR3C2, MC2R, CRHR1 CTNNB1 2715/4885WNT3A 1560/4885LMNA 2076/4885
US-10005725-B2 Method for producing pyrrole derivative, and intermediate thereof NR3C2, MC2R, CYP11B2 CTNNB1 4201/4885WNT3A 2931/4885LMNA 4062/4885
US-20070021445-A1 Pyridopyrimidine protein tyrosine phosphatase inhibitors PTPRF, PTPN1, PTPRCAP CTNNB1 2561/4885WNT3A 2847/4885LMNA 4736/4885
US-20100280021-A1 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS PTPRF, PTPN1, PTPRCAP CTNNB1 2561/4885WNT3A 2847/4885LMNA 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback